From the Guidelines
Altered mental status in UTI is considered a form of metabolic encephalopathy, specifically urinary tract infection-associated encephalopathy. This condition occurs when a urinary tract infection leads to systemic inflammatory responses and metabolic disturbances that affect brain function. The encephalopathy develops due to several mechanisms including systemic inflammation, cytokine release, endotoxins from bacteria, electrolyte imbalances, and sometimes direct infection spread. This condition is particularly common in elderly patients, where a UTI may present primarily with confusion or altered mental status rather than typical urinary symptoms.
Key Points
- Management involves prompt treatment of the underlying UTI with appropriate antibiotics based on culture results (common choices include nitrofurantoin 100mg twice daily for 5-7 days, trimethoprim-sulfamethoxazole DS twice daily for 3 days, or fluoroquinolones like ciprofloxacin 250-500mg twice daily for 3-7 days depending on infection severity) 1.
- Additionally, supportive care including hydration, correction of electrolyte abnormalities, and management of fever is essential 1.
- The altered mental status typically improves as the infection resolves with appropriate treatment, though recovery may be slower in elderly patients or those with underlying cognitive impairments.
- In older patients with functional and/or cognitive impairment with bacteriuria and delirium (acute mental status change, confusion) and without local genitourinary symptoms or other systemic signs of infection, assessment for other causes and careful observation rather than antimicrobial treatment is recommended 1.
Considerations
- Current evidence does not suggest a causal relationship between bacteriuria and presentations without classic localizing UTI symptoms, such as changes in mental status or falls 1.
- Treatment of ASB in patients with delirium has not been shown to have any beneficial impact in clinical outcomes compared to no treatment, including reducing severity or duration of delirium and reducing risk of sepsis, death, or hospitalizations 1.
From the Research
Altered Mental Status in UTI
- Altered mental status (AMS) in patients with urinary tract infections (UTI) can be a complex issue, and its classification as toxic or metabolic encephalopathy is not straightforward 2.
- According to a study published in the Journal of the American Pharmacists Association, patients with pyuria and AMS who were treated with antibiotics did not have a significant difference in 30-day hospital readmission rates compared to those who were not treated 3.
- Another study published in Hospital Pharmacy found that asymptomatic treatment of UTI was common in psychiatric inpatients, and all patients with AMS were asymptomatic, suggesting that AMS may not be a reliable indicator of UTI 4.
- A review article in Continuum (Minneapolis, Minn.) discusses the various causes of altered mental status, including systemic infections and metabolic derangements, and emphasizes the importance of a systematic approach to diagnosis and treatment 2.
- The creation and implementation of a UTI diagnostic and treatment algorithm for psychiatric inpatients with communication barriers may help improve diagnosis and treatment of UTIs in these patients, and reduce unnecessary antibiotic use 5.
- A study published in The Senior Care Pharmacist highlights the importance of distinguishing between colonization and infection in older patients with ASB, and exploring alternative diagnoses for AMS in the absence of UTI-specific symptoms 6.
Classification of Altered Mental Status
- The classification of altered mental status in UTI as toxic or metabolic encephalopathy is not clearly defined in the literature 2.
- However, studies suggest that AMS in patients with UTI may be related to a variety of factors, including systemic infection, metabolic derangements, and other underlying medical conditions 3, 4, 5, 6.
- Further research is needed to clarify the relationship between UTI and altered mental status, and to develop evidence-based guidelines for diagnosis and treatment.